Table 1. Phylogenetic analysis of 16 RNA structures in the HIV-1 genome.
name | positiona | subtype | Prototype sequenceb | nt differencesc | RNA structure | |
---|---|---|---|---|---|---|
ΔG (kcal/mol)d |
Conservatione |
|||||
A |
1076–1142 |
NL4–3 |
|
|
-22.9 |
+ |
gag, p24 |
A |
2/6 (33%) |
4 |
-22.9 |
+ |
|
|
B |
23/235 (10%) |
1 |
-22.9 |
+ |
|
|
C |
12/397 (3%) |
9 |
-16.1 |
- |
|
|
D |
6/49 (12%) |
4 |
-21.3 |
+ |
|
B |
1459–1522 |
NL4–3 |
|
|
-12.5 |
- |
gag, p2 |
A |
1/6 (17%) |
13 (3 del) |
-8.0 |
- |
|
|
B |
7/371 (2%) |
2 |
-15.0 |
- |
|
|
C |
3/399 (1%) |
23 (4 del) |
-11.3 |
- |
|
|
D |
2/51 (4%) |
15 |
-11.3 |
- |
|
C |
1823–1859 |
NL4–3 |
|
|
-19.1 |
+ |
gag, p6 |
A |
2/6 (33%) |
11 |
-7.9 |
1/2Bf |
|
pol, prot |
B |
41/371 (11%) |
2 |
-18.1 |
+ |
|
|
C |
11/399 (3%) |
10 |
-17.1 |
- |
|
|
D |
3/51 (6%) |
5 |
-17.5 |
+ |
|
D |
2388–2484 |
NL4–3 |
|
|
-23.1 |
- |
pol, RT |
A |
1/6 (17%) |
10 |
-34.1 |
- |
|
|
B |
7/235 (3%) |
2 |
-21.7 |
- |
|
|
C |
10/397 (3%) |
8 |
-27.5 |
- |
|
|
D |
1/49 (2%) |
6 |
-21.4 |
- |
|
E POL1 |
2619–2686 |
NL4–3 |
|
|
-20.7 |
+ |
pol, RT |
A |
1/6 (17%) |
6 |
-9.2 |
+ |
|
|
B |
39/235 (17%) |
1 |
-18.5 |
+ |
|
|
C |
26/397 (7%) |
4 |
-17.4 |
1/2Bf |
|
|
D |
6/49 (12%) |
3 |
-15.0 |
1/2Bf |
|
|
CPZ |
1/9 (9%) |
26 |
-12.4 |
+ |
|
F POL2 |
2781–2835 |
NL4–3 |
|
|
-23.2 |
+ |
pol, RT |
A |
2/6 (33%) |
6 |
-14.5 |
1/2Af |
|
|
B |
53/235 (21%) |
0 |
-23.2 |
+ |
|
|
C |
122/397 (31%) |
4 |
-20.2 |
+ |
|
|
D |
8/49 (16%) |
3 |
-17.6 |
+ |
|
|
CPZ |
8/49 (16%) |
3 |
-17.6 |
+ |
|
G |
3285–3358 |
NL4–3 |
|
|
-23.4 |
- |
pol, RT |
A |
1/6 (17%) |
8 |
-25.2 |
- |
|
|
B |
25/235 (11%) |
1 |
-23.9 |
- |
|
|
C |
55/396 (14%) |
5 |
-22.5 |
1/2Bf |
|
|
D |
4/49 (8%) |
3 |
-23.9 |
- |
|
H POL3 |
3606–3639 |
NL4–3 |
|
|
-5.8 |
+ |
pol, RNase H |
A |
1/6 (17%) |
6 |
-5.1 |
+ |
|
|
B |
59/235 (25%) |
2 |
-2.0 |
+ |
|
|
C |
140/395 (35%) |
1 |
-5.8 |
+ |
|
|
D |
17/49 (35%) |
1 |
-5.8 |
+ |
|
|
CPZ |
17/49 (35%) |
1 |
-5.8 |
+ |
|
I |
5303–5343 |
NL4–3 |
|
|
-12.3 |
- |
vpr |
A |
3/6 (50%) |
5 |
-3.9 |
- |
|
|
B |
35/234 (15%) |
1 |
-9.8 |
- |
|
|
C |
78/397 (20%) |
6 |
-4.5 |
- |
|
|
D |
6/49 (12%) |
3 |
-4.5 |
- |
|
J |
5530–5581 |
NL4–3 |
|
|
-12.4 |
+ |
tat(1), rev(1) |
A |
1/6 (17%) |
14 |
-14.7 |
- |
|
|
B |
6/371 (2%) |
4 |
-10.1 |
- |
|
|
C |
17/399 (4%) |
12 |
-14.9 |
- |
|
|
D |
2/51 (4%) |
11 |
-6.9 |
- |
|
K |
5600–5645 |
NL4–3 |
|
|
-7.6 |
- |
|
A |
1/6 (17%) |
21 |
-6.5 |
- |
|
|
B |
2/235 (1%) |
7 |
-8.8 |
- |
|
|
C |
3/397 (1%) |
30 |
-0.4 |
- |
|
|
D |
2/49 (4%) |
8 |
-8.8 |
- |
|
L |
6536–6598 |
NL4–3 |
|
|
-17.8 |
- |
env, gp120 |
A |
1/6 (17%) |
11 |
-10.3 |
- |
|
|
B |
6/371 (2%) |
4 |
-8.8 |
- |
|
|
C |
5/398 (1%) |
13 |
-8.4 |
- |
|
|
D |
2/51 (4%) |
9 |
-11.6 |
- |
|
M |
6982–7016 |
NL4–3 |
|
|
-7.9 |
+ |
env, gp120 |
A |
1/6 (17%) |
17 |
-1.3 |
- |
|
|
B |
1/235 (< 1%) |
14 |
0.7 |
- |
|
|
C |
1/397 (< 1%) |
17 (7 del) |
-0.6 |
- |
|
|
D |
1/49 (2%) |
13 |
-1.7 |
- |
|
N |
8455–8505 |
NL4–3 |
|
|
-18.3 |
+ |
nef, LTR |
A |
1/6 (17%) |
11 |
-11.8 |
- |
|
|
B |
24/370 (7%) |
partial del |
-1.6 |
- |
|
|
C |
8/399 (2%) |
13 |
-15.0 |
+ |
|
|
D |
4/51 (8%) |
7 |
-13.4 |
- |
|
O NEF1 |
8723–8773 |
NL4–3 |
|
|
-26.6 |
+ |
nef, LTR |
A |
1/6 (17%) |
8 |
-13.3 |
1/2Bf |
|
|
B |
16/219 (7%) |
2 |
-19.0 |
+ |
|
|
C |
49/396 (12%) |
4 |
-25.1 |
+ |
|
|
D |
9/48 (19%) |
4 |
-19.6 |
+ |
|
|
CPZ |
1/11 (9%) |
10 |
-17.5 |
+ |
|
P | 8867–8906 |
NL4–3 |
|
|
-19.5 |
+ |
nef, LTR |
A |
3/6 (50%) |
13 |
-11.0 |
+ |
|
|
B |
15/59 (25%) |
6 |
-7.1 |
+ |
|
|
C |
2/25 (8%) |
14 |
-6.0 |
- |
|
D | 1/4 (25%) | 11 | -3.9 | - |
a) NL4-3 coordinates
b) Number of virus isolates that match the exact prototype sequence, which was identified by PrimAlign (Los Alamos HIV database)
c) Compared with NL4-3
d) Calculated by mfold for the prototype sequence
e) Structural similarity between SHAPE model2 and predicted mfold structure; structure maintained = +; structure changed = -
f) 1/2A = only first domain maintained, 1/2B = only second domain maintained.